Dd. Miller et al., Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia, BIOL PSYCHI, 49(8), 2001, pp. 704-715
Background: Atypical antipsychotics, such as risperidone, have been shown t
o be more effective for the treatment of the symptoms of schizophrenia and
have a greater beneficial effect on neurocognition compared to the conventi
onal antipsychotics. The present study used [O-15]H2O positron emission tom
ography imaging of regional cerebral blood flow to examine and compare the
effects of haloperidol and risperidone on brain function.
Methods: Thirty-two subjects with schizophrenia participated in the study.
Each subject was scanned in a medication-free state, and after being on a s
table clinically assigned dose of either risperidone or haloperidol for 3 w
eeks. The off-medication scan was subtracted from the on-medication scan. u
sing a,within-subjects design. A randomization analysis was used to determi
ne differences between the effects of haloperidol and risperidone on region
al cerebral blood flow.
Results: Haloperidol was associated with a significantly greater increase i
n regional cerebral blood flow in the left putamen and posterior cingulate,
and a significantly greater decrease in regional cerebral blood flow in fr
ontal regions compared to risperidone. Risperidone was associated with a si
gnificantly greater decrease in regional cerebral blood flow in the cerebel
lum bilaterally compared to haloperidol.
Conclusions: The results show that risperidone and haloperidol have signifi
cantly different effects on brain function, which may be related to their d
ifferences in efficacy and side effects. Further work is required to more p
recisely determine the mechanisms by which different antipsychotic medicati
ons exert their therapeutic effects on the clinical symptoms and cognition
in schizophrenia. These findings emphasize the importance of controlling fo
r both medication status and the individual antipsychotic in neuroimaging s
tudies. Biol Psychiatry (C) 2001 Society of Biological Psychiatry.